Literature DB >> 12545320

Myocardial perfusion and coronary flow reserve assessed by positron emission tomography in patients after Fontan-like operations.

M Hauser1, F M Bengel, A Kühn, U Sauer, S G Nekolla, A Eicken, M Schwaiger, J Hess.   

Abstract

Ventricular dysfunction in patients after Fontan-like operations (FLOs) is a serious complication that might contribute to poor long-term results. Ischemic heart disease will have debilitating consequences on a Fontan heart. Ten patients (15.8 +/- 5.01 years) after FLO had transesophageal echocardiography and cardiac catheterization 9.3 +/- 4.2 years after surgery. Myocardial perfusion was assessed by NH3-positron emission tomography (rest/adenosine) and compared with that of 10 healthy adults (26.1 +/- 6.3 years). Ventricular function was normal in 4 and reduced in 6 patients; end systolic and end diastolic meridional wall stress was significantly elevated in the FLO group. Coronary angiography revealed no stenosis of the coronaries. Compared to normals, myocardial blood flow (MBF) at rest was higher in the FLO group (0.99 +/- 0.25 vs 0.77 +/- 0.17 ml/g/min, p <0.05), whereas MBF after vasodilatation (2.12 +/- 0.78 vs 3.10 +/- 0.85 ml/g/min, p <0.05) and coronary flow reserve (CFR) was reduced (2.5 +/- 0.88 vs 4.1 +/- 1.01, p <0.05), especially in those with impaired ventricular function. Coronary vascular resistance after vasodilatation was elevated in the FLO group (38.2 +/- 17.4 vs 24.5 +/- 8.3 mmHg/ml/g/min, p <0.05). Altered MBF, increased meridional wall stress, and impaired CFR are common findings in FLO. Attenuated CFR and reduced ventricular function are significantly correlated and may be risk factors for the long-term outcome.

Entities:  

Mesh:

Year:  2003        PMID: 12545320     DOI: 10.1007/s00246-002-0355-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  Factors that influence the development of atrial flutter after the Fontan operation.

Authors:  S B Fishberger; G Wernovsky; T L Gentles; K Gauvreau; J Burnett; J E Mayer; E P Walsh
Journal:  J Thorac Cardiovasc Surg       Date:  1997-01       Impact factor: 5.209

2.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.

Authors:  G D Hutchins; M Schwaiger; K C Rosenspire; J Krivokapich; H Schelbert; D E Kuhl
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

3.  Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography.

Authors:  O Muzik; S M Paridon; T P Singh; W R Morrow; F Dayanikli; M F Di Carli
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

4.  Experience with the Fontan procedure.

Authors:  H Laks; J C Milliken; J K Perloff; W E Hellenbrand; B L George; A Chin; T G Di Sessa; R G Williams
Journal:  J Thorac Cardiovasc Surg       Date:  1984-12       Impact factor: 5.209

5.  Myocardial blood flow and flow reserve after coronary reimplantation in patients after arterial switch and ross operation.

Authors:  M Hauser; F M Bengel; A Kühn; U Sauer; S Zylla; S L Braun; S G Nekolla; R Oberhoffer; R Lange; M Schwaiger; J Hess
Journal:  Circulation       Date:  2001-04-10       Impact factor: 29.690

6.  Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992.

Authors:  F Cetta; R H Feldt; P W O'Leary; D D Mair; C A Warnes; D J Driscoll; D J Hagler; C J Porter; K P Offord; H V Schaff; F J Puga; G K Danielson
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

7.  End-systolic dimension-wall thickness relations during myocardial ischemia in conscious dogs. A new approach for defining regional function.

Authors:  G Osakada; O M Hess; K P Gallagher; W S Kemper; J Ross
Journal:  Am J Cardiol       Date:  1983-06       Impact factor: 2.778

Review 8.  Contractile proteins and sarcoplasmic reticulum calcium-ATPase gene expression in the hypertrophied and failing heart.

Authors:  K Schwartz; L Carrier; A M Lompré; J J Mercadier; K R Boheler
Journal:  Basic Res Cardiol       Date:  1992       Impact factor: 17.165

9.  Correlation between acute reductions in myocardial blood flow and function in conscious dogs.

Authors:  S F Vatner
Journal:  Circ Res       Date:  1980-08       Impact factor: 17.367

10.  Abnormal patterns of intraventricular flow and diastolic filling after the Fontan operation: evidence for incoordinate ventricular wall motion.

Authors:  D J Penny; M L Rigby; A N Redington
Journal:  Br Heart J       Date:  1991-11
View more
  4 in total

1.  Site of coronary sinus drainage does not significantly affect coronary flow reserve in patients long term after Fontan operation.

Authors:  A Eicken; W Sebening; T Genz; H Kaemmerer; R Lange; R Busch; J Hess
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

2.  Assessing ST Segment Changes and Ischemia During Exercise Stress Testing in Patients with Hypoplastic Left Heart Syndrome and Fontan Palliation.

Authors:  William Buck Kyle; Susan W Denfield; Santiago O Valdes; Daniel J Penny; Elijah H Bolin; Keila N Lopez
Journal:  Pediatr Cardiol       Date:  2016-01-04       Impact factor: 1.655

Review 3.  Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease.

Authors:  Sara L Partington; Anne Marie Valente; Michael Landzberg; Frederick Grant; Marcelo F Di Carli; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2015-07-01       Impact factor: 5.952

4.  Autologous skeletal myoblast patch implantation prevents the deterioration of myocardial ischemia and right heart dysfunction in a pressure-overloaded right heart porcine model.

Authors:  Kanta Araki; Shigeru Miyagawa; Takuji Kawamura; Ryo Ishii; Tadashi Watabe; Akima Harada; Masaki Taira; Koichi Toda; Toru Kuratani; Takayoshi Ueno; Yoshiki Sawa
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.